# Interleukin-13 Treatment of Living Lung Tissue Model Alters the Metabolome and Proteome—A Nano-DESI MS Metabolomics and Shotgun Proteomics Study

**Authors:** Gábor Tóth, Anastasia Golubova, Alexander Falk, Sara Bergström Lind, Mark Nicholas, Ingela Lanekoff

PMC · DOI: 10.3390/ijms25095034 · International Journal of Molecular Sciences · 2024-05-05

## TL;DR

This study uses a new method to analyze how IL-13 affects lung cells, revealing changes in metabolism and proteins that could help understand asthma better.

## Contribution

The study introduces nano-DESI MS for in vivo metabolomic analysis of ALI lung-cell layers and links metabolic changes to proteomic profiles.

## Key findings

- Nano-DESI MS successfully monitored molecular transport and metabolic responses in ALI lung cells.
- IL-13 exposure led to metabolic remodeling correlated with proteomic changes after histamine and corticosteroid treatments.
- The study identified new markers that could guide future research on lung diseases like asthma.

## Abstract

Asthma is a chronic respiratory disease with one of the largest numbers of cases in the world; thus, constant investigation and technical development are needed to unravel the underlying biochemical mechanisms. In this study, we aimed to develop a nano-DESI MS method for the in vivo characterization of the cellular metabolome. Using air–liquid interface (ALI) cell layers, we studied the role of Interleukin-13 (IL-13) on differentiated lung epithelial cells acting as a lung tissue model. We demonstrate the feasibility of nano-DESI MS for the in vivo monitoring of basal–apical molecular transport, and the subsequent endogenous metabolic response, for the first time. Conserving the integrity of the ALI lung-cell layer enabled us to perform temporally resolved metabolomic characterization followed by “bottom-up” proteomics on the same population of cells. Metabolic remodeling was observed upon histamine and corticosteroid treatment of the IL-13-exposed lung cell monolayers, in correlation with alterations in the proteomic profile. This proof of principle study demonstrates the utility of in vivo nano-DESI MS for characterizing ALI tissue layers, and the new markers identified in our study provide a good starting point for future, larger-scale studies.

## Linked entities

- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}
- **Diseases:** respiratory disease (MESH:D012140), Asthma (MESH:D001249)
- **Chemicals:** histamine (MESH:D006632)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11084154/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11084154/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC11084154/full.md

---
Source: https://tomesphere.com/paper/PMC11084154